Array BioPharma (ARRY) Enters Deal with Amgen (AMGN) For Type 2 Diabetes
Tweet Send to a Friend
After the close, Array BioPharma Inc. (NASDAQ: ARRY) and Amgen Inc. (NASDAQ: AMGN) announced that they entered into an agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
